Literature DB >> 21761121

Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia.

Ashu Rastogi1, Sanjay Kumar Bhadada, Anil Bhansali.   

Abstract

Fibrous dysplasia is an uncommon metabolic bone disease. Medical management is often not rewarding. Index patient, a 15-year-old girl with history of recurrent fractures on trivial trauma was treated with pamidronate. She showed good outcome with symptomatic improvement and no new fractures over 3 year duration of follow up.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21761121     DOI： 10.1007/s12098-011-0521-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  10 in total

Review 1.  Common benign lesions of bone in children and adolescents.

Authors:  J Sybil Biermann
Journal:  J Pediatr Orthop       Date:  2002 Mar-Apr       Impact factor: 2.324

2.  Does Paget's disease exist in India?: A series of 21 patients.

Authors:  S Bhadada; A Bhansali; A G Unnikrishnan; R Khadgawat; S K Singh; A Mithal; U N Saikia
Journal:  J Assoc Physicians India       Date:  2006-07

3.  Fibrous dysplasia.

Authors:  S Bhadada; D C Sharma; L K Gupta; A Gupta; R Gupta
Journal:  J Indian Med Assoc       Date:  1998-03

4.  Fibrous dysplasia involving the skull base and temporal bone.

Authors:  L R Lustig; M J Holliday; E F McCarthy; G T Nager
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-10

Review 5.  Bisphosphonate therapy for fibrous dysplasia.

Authors:  Linda A DiMeglio
Journal:  Pediatr Endocrinol Rev       Date:  2007-08

6.  Osteogenesis imperfecta.

Authors:  S K Bhadada; R Santosh; A Bhansali; V Upreti; P Dutta
Journal:  J Assoc Physicians India       Date:  2009-01

7.  Hyperthyroidism with fibrous dysplasia: an unusual presentation of McCune-Albright syndrome.

Authors:  M H Bhat; S Bhadada; P Dutta; A Bhansali; B R Mittal
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-05       Impact factor: 2.949

Review 8.  Acromegaly with fibrous dysplasia: McCune-Albright Syndrome -- clinical studies in 3 cases and brief review of literature--.

Authors:  Anil Bhansali; Bhawani S Sharma; Polupoina Sreenivasulu; Paramjit Singh; Rakesh K Vashisth; Radharaman J Dash
Journal:  Endocr J       Date:  2003-12       Impact factor: 2.349

9.  Oral bisphosphonates in polyostotic fibrous dysplasia.

Authors:  V V Khadilkar; A V Khadilkar; G B Maskati
Journal:  Indian Pediatr       Date:  2003-09       Impact factor: 1.411

10.  Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.

Authors:  M Riminucci; L W Fisher; A Shenker; A M Spiegel; P Bianco; P Gehron Robey
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307
  10 in total
  2 in total

1.  Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia.

Authors:  Chiara Di Pede; Sabrina Congedi; Sara Rossin; Antuan Divisic; Alesandra De Gregorio; Caterina Agosto; Igor Catalano; Alessandro Mazza; Leonardo Sartori; Stefano Masiero; Franca Benini
Journal:  Case Rep Pediatr       Date:  2016-09-22

Review 2.  Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors:  Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal:  Br J Clin Pharmacol       Date:  2018-12-25       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.